Patents by Inventor Shobha V. Kamanna

Shobha V. Kamanna has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Indication for use of niacin (nicotinic acid) for treatment and reversal of fatty liver disease
    Patent number: 9072732
    Abstract: Niacin prevents and/or reverses the development of experimental hepatic steatosis, deposition of triglycerides in liver and serum of individuals, deposition of total cholesterol in liver and serum in individuals, and inhibit liver lipid peroxidation and oxidative stress in individuals at risk of developing fatty liver disease or NAFLD. In cultured human hepatocytes, niacin inhibits alcohol-induced fat accumulation.
    Type: Grant
    Filed: November 22, 2011
    Date of Patent: July 7, 2015
    Assignees: The Regents of the University of California, Veterans Affairs Health Care System
    Inventors: Moti L. Kashyap, Vaijinath S. Kamanna, Shobha V. Kamanna
  • INDICATION FOR USE OF NIACIN (NICOTINIC ACID) FOR TREATMENT, PREVENTION AND REVERSAL OF FATTY LIVER DISEASE
    Publication number: 20130303548
    Abstract: Niacin prevents and/or reverses the development of experimental hepatic steatosis, deposition of triglycerides in liver and serum of individuals, deposition of total cholesterol in liver and serum in individuals, and inhibit liver lipid peroxidation and oxidative stress in individuals at risk of developing fatty liver disease or NAFLD. In cultured human hepatocytes, niacin inhibits alcohol-induced fat accumulation.
    Type: Application
    Filed: November 22, 2011
    Publication date: November 14, 2013
    Applicant: The Regents of the University of California
    Inventors: Moti L. Kashyap, Shobha V. Kamanna, Vaijinath S. Kamanna